Therapeutic Angiogenesis Using Basic Fibroblast Growth Factor in Combination with a Collagen Matrix in Chronic Hindlimb Ischemia

<table>Characterization of the CM and the bFGF-CM complex. (a) Gross overview of the bFGF-CM complex. (b) Scanning electron microscopy indicated that bFGF-CM had a multiporous structure (<svg height="11.0125" id="M12" style="vertical-align:-0.17555pt" version="1.1" viewbox="0 0 62.912498 11.0125" width="62.912498" xmlns="http://www.w3.org/2000/svg">
<g transform="matrix(1.25,0,0,-1.25,0,11.0125)">
<g transform="translate(72,-63.19)">
<text transform="matrix(1,0,0,-1,-71.95,63.41)">
<tspan style="font-size: 12.50px; " x="0" y="0">b</tspan>
<tspan style="font-size: 12.50px; " x="6.2515001" y="0">a</tspan>
<tspan style="font-size: 12.50px; " x="11.802832" y="0">r</tspan>
<tspan style="font-size: 12.50px; " x="19.429663" y="0">=</tspan>
<tspan style="font-size: 12.50px; " x="31.470051" y="0">1</tspan>
<tspan style="font-size: 12.50px; " x="37.72155" y="0">0</tspan>
<tspan style="font-size: 12.50px; " x="43.973049" y="0">0</tspan>
</text>
</g>
</g>
</svg> <i>μ</i>m). (c) Proliferation assays showed that CM did not have a cytotoxic effect on MSCs. (d) Rehydration analysis of the CM. (e) The kinetic profile of bFGF release. (f) The bioactivity analysis of the bFGF released from the bFGF-CM complex (<svg height="15.4375" id="M13" style="vertical-align:-3.13504pt" version="1.1" viewbox="0 0 142.3 15.4375" width="142.3" xmlns="http://www.w3.org/2000/svg">
<g transform="matrix(1.25,0,0,-1.25,0,15.4375)">
<g transform="translate(72,-59.65)">
<text transform="matrix(1,0,0,-1,-69.87,67.83)">
<tspan style="font-size: 8.75px; " x="0" y="0">∗</tspan>
</text>
<text transform="matrix(1,0,0,-1,-64.79,61.87)">
<tspan style="font-size: 12.50px; " x="0" y="0">𝑃</tspan>
<tspan style="font-size: 12.50px; " x="10.9" y="-0.95999998">&lt;</tspan>
<tspan style="font-size: 12.50px; " x="22.927885" y="-0.95999998">0</tspan>
<tspan style="font-size: 12.50px; " x="29.179386" y="-0.95999998">.</tspan>
<tspan style="font-size: 12.50px; " x="32.305138" y="-0.95999998">0</tspan>
<tspan style="font-size: 12.50px; " x="38.556637" y="-0.95999998">5</tspan>
<tspan style="font-size: 12.50px; " x="44.808136" y="-0.95999998">,</tspan>
</text>
<text transform="matrix(1,0,0,-1,-12.68,67.83)">
<tspan style="font-size: 8.75px; " x="0" y="0">∗</tspan>
<tspan style="font-size: 8.75px; " x="4.5772958" y="0">∗</tspan>
</text>
<text transform="matrix(1,0,0,-1,-3.03,61.87)">
<tspan style="font-size: 12.50px; " x="0" y="0">𝑃</tspan>
<tspan style="font-size: 12.50px; " x="10.9" y="-0.95999998">&lt;</tspan>
<tspan style="font-size: 12.50px; " x="22.94039" y="-0.95999998">0</tspan>
<tspan style="font-size: 12.50px; " x="29.191889" y="-0.95999998">.</tspan>
<tspan style="font-size: 12.50px; " x="32.317638" y="-0.95999998">0</tspan>
<tspan style="font-size: 12.50px; " x="38.569138" y="-0.95999998">1</tspan>
</text>
</g>
</g>
</svg>).</table>

The Scientific World Journal

fig1

Figure 1

Figure 1: Therapeutic Angiogenesis Using Basic Fibroblast Growth Factor in Combination with a Collagen Matrix in Chronic Hindlimb Ischemia 